A New Era For FDA Regulation Of Cell And Tissue Products
The May 31 expiration of the U.S. Food and Drug Administration's enforcement discretion period for the regulatory oversight of cell and tissue products, coupled with a June 2 decision in the...To view the full article, register now.
Already a subscriber? Click here to view full article